The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patterns of chemotherapy (CT) use in a U.S.-wide cohort of patients (pts) with metastatic gastric cancer (MGC).
 
Thomas Adam Abrams
Honoraria - Celgene; Genentech/Roche; Merrimack
Consulting or Advisory Role - Aduro Biotech; Bristol-Myers Squibb
Research Funding - Celgene; Lilly
Travel, Accommodations, Expenses - Lilly
 
Gary Meyer
Employment - IntrinsiQ
 
Lisa M. Hess
Employment - Lilly
Research Funding - Lilly
 
Yajun Zhu
Employment - Lilly
 
Sui Zhang
No Relationships to Disclose
 
Astra M. Liepa
Employment - Lilly
Stock and Other Ownership Interests - Amgen; Lilly
 
Jeffrey A. Meyerhardt
Honoraria - Chugai Pharma
Consulting or Advisory Role - Genentech/Roche
 
Deborah Schrag
Other Relationship - JAMA-Journal of the American Medical Association
 
Peter C. Enzinger
Consulting or Advisory Role - Five Prime Therapeutics; Merck
 
Charles S. Fuchs
Consulting or Advisory Role - Agios; Bayer; Dicerna; Entrinsic Health; Five Prime Therapeutics; Genentech/Roche; Gilead Sciences; KEW; Lilly; Merck; Merrimack; Sanofi; Taiho Pharmaceutical